MedTrace Logo

Effectiveness of Deep Transcranial Magnetic Stimulation in Depression

NCT01409304 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2013-01-18

No results posted yet for this study

Summary

We intend to investigate whether deep transcranial magnetic stimulation (DTMS), a novel brain stimulation technique, is effective for treating major depression. We hypothesize that 4 weeks of DTMS will be associated with significant improvements in depressive and anxious symptoms without significant side effects.

Conditions

Interventions

DEVICE

Deep Transcranial Magnetic Stimulation (DTMS)

DTMS will be administered according to the following parameters: 18 Hz in 84 trains of 2 seconds duration, with 20 seconds inter-train interval (3,024 pulses per session) at 120% of the resting motor threshold.

Sponsors & Collaborators

  • Brainsway

    collaborator INDUSTRY

  • Douglas Mental Health University Institute

    lead OTHER

Principal Investigators

  • Marcelo T Berlim, MD, MSc · McGill University & Douglas Mental Health University Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01409304 on ClinicalTrials.gov